Skip to main content
Top
Published in: International Urology and Nephrology 4/2017

01-04-2017 | Nephrology - Original Paper

Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis

Authors: Jun Zhang, Bo Wang, Rongke Li, Long Ge, Kee-Hsin Chen, Jinhui Tian

Published in: International Urology and Nephrology | Issue 4/2017

Login to get access

Abstract

Purpose

The purpose of our study is to carry out a Bayesian network meta-analysis comparing the efficacy of different antimicrobial lock solutions (ALS) for prevention of catheter-related infections (CRI) in patients with hemodialysis (HD) and ranking these ALS for practical consideration.

Methods

We searched six electronic databases, earlier relevant meta-analysis and reference lists of included studies for randomized controlled trials (RCTs) that compared ALS for preventing episodes of CRI in patients with HD either head-to-head or against control interventions using non-ALS. Two authors independently assessed the methodological quality of included studies using the Cochrane risk of bias tool and extracted relevant information according to a predesigned extraction form. Data were analysed using the WinBUGS (V.1.4.3) and the Stata (V.13.0).

Results

Finally, 18 studies involving 2395 patients and evaluating 9 ALS strategies were included. Network meta-analysis showed that gentamicin plus citrate (OR 0.07, 95% CrI 0.00–0.48) and gentamicin plus heparin (OR 0.04, 95% CrI 0.00–0.23) were statistically superior to heparin alone in terms of reducing CRBSI. For exit site infection and all-cause mortality, no significant difference in the intervention effect (p > 0.05) was detected for all included ALS when compared to heparin. Moreover, all ALS were similar in efficacy (p > 0.05) from each other for CRBSI, exit site infection and all-cause mortality.

Conclusions

Our findings indicated that gentamicin plus heparin may be selected for the prophylaxis of CRI in patients undergoing HD with CVCs. Whether this strategy will lead to antimicrobial resistance remains unclear in view of the relatively short duration of included studies. More attentions should be made regarding head-to-head comparisons of the most commonly used ALS in this field.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rehman R, Schmidt RJ, Moss AH (2009) Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 4:456–460CrossRefPubMed Rehman R, Schmidt RJ, Moss AH (2009) Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 4:456–460CrossRefPubMed
2.
go back to reference Rayner HC, Besarab A, Brown WW et al (2004) Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44:22–26CrossRefPubMed Rayner HC, Besarab A, Brown WW et al (2004) Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44:22–26CrossRefPubMed
3.
go back to reference Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305–316CrossRefPubMed Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305–316CrossRefPubMed
4.
go back to reference Lacson E Jr, Lazarus JM, Himmelfarb J et al (2007) Balancing fistula first with catheters last. Am J Kidney Dis 50:379–395CrossRefPubMed Lacson E Jr, Lazarus JM, Himmelfarb J et al (2007) Balancing fistula first with catheters last. Am J Kidney Dis 50:379–395CrossRefPubMed
5.
go back to reference Taylor G, Gravel D, Johnston L et al (2002) Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23:716–720CrossRefPubMed Taylor G, Gravel D, Johnston L et al (2002) Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23:716–720CrossRefPubMed
6.
go back to reference Silva TN, de Marchi D, Mendes ML et al (2014) Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review. Hemodial Int 18:15–23CrossRefPubMed Silva TN, de Marchi D, Mendes ML et al (2014) Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review. Hemodial Int 18:15–23CrossRefPubMed
7.
go back to reference Katneni R, Hedayati SS (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3:256–266CrossRefPubMed Katneni R, Hedayati SS (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3:256–266CrossRefPubMed
8.
go back to reference Ishani A, Collins AJ, Herzog CA et al (2005) Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311–318CrossRefPubMed Ishani A, Collins AJ, Herzog CA et al (2005) Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311–318CrossRefPubMed
9.
go back to reference Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539CrossRefPubMed Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539CrossRefPubMed
10.
go back to reference Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322CrossRefPubMed Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322CrossRefPubMed
11.
go back to reference Donlan RM (2001) Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33:1387–1392CrossRefPubMed Donlan RM (2001) Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33:1387–1392CrossRefPubMed
13.
go back to reference Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133–2139CrossRefPubMed Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133–2139CrossRefPubMed
14.
go back to reference Betjes MG, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546–1551CrossRefPubMed Betjes MG, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546–1551CrossRefPubMed
15.
go back to reference Bleyer AJ, Mason L, Russell G et al (2005) A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520–524CrossRefPubMed Bleyer AJ, Mason L, Russell G et al (2005) A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520–524CrossRefPubMed
16.
go back to reference Snaterse M, Rüger W, Scholte Op Reimer WJ et al (2010) Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1–11CrossRefPubMed Snaterse M, Rüger W, Scholte Op Reimer WJ et al (2010) Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1–11CrossRefPubMed
17.
go back to reference Rabindranath KS, Bansal T, Adams J et al (2009) Systematic review of antimicrobials for the prevention of hemodialysis catheter-related infections. Nephrol Dial Transplant 24:3763–3774CrossRefPubMed Rabindranath KS, Bansal T, Adams J et al (2009) Systematic review of antimicrobials for the prevention of hemodialysis catheter-related infections. Nephrol Dial Transplant 24:3763–3774CrossRefPubMed
18.
go back to reference Yahav D, Rozen-Zvi B, Gafter-Gvili A et al (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93CrossRefPubMed Yahav D, Rozen-Zvi B, Gafter-Gvili A et al (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93CrossRefPubMed
19.
go back to reference Liu H, Liu H, Deng J et al (2014) Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif 37:179–187CrossRefPubMed Liu H, Liu H, Deng J et al (2014) Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif 37:179–187CrossRefPubMed
20.
go back to reference Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63:479–490CrossRefPubMed Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63:479–490CrossRefPubMed
21.
go back to reference Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105–3124CrossRefPubMed Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105–3124CrossRefPubMed
22.
go back to reference Jansen JP, Crawford B, Bergman G et al (2008) Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 11:956–964CrossRefPubMed Jansen JP, Crawford B, Bergman G et al (2008) Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 11:956–964CrossRefPubMed
23.
go back to reference Catalá-López F, Tobías A, Cameron C et al (2014) Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 34:1489–1496CrossRefPubMed Catalá-López F, Tobías A, Cameron C et al (2014) Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 34:1489–1496CrossRefPubMed
24.
go back to reference O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1–29PubMed O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1–29PubMed
25.
27.
go back to reference Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–445 Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–445
28.
go back to reference McIntyre CW, Hulme LJ, Taal M et al (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801–805CrossRefPubMed McIntyre CW, Hulme LJ, Taal M et al (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801–805CrossRefPubMed
29.
go back to reference Saxena AK, Panhotra BR (2005) The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 18:755–763PubMed Saxena AK, Panhotra BR (2005) The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 18:755–763PubMed
30.
go back to reference Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777CrossRefPubMed Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777CrossRefPubMed
31.
go back to reference Nori US, Manoharan A, Yee J et al (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596–605CrossRefPubMed Nori US, Manoharan A, Yee J et al (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596–605CrossRefPubMed
32.
go back to reference Macrae JM, Dojcinovic I, Djurdjev O et al (2009) Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3:369–374CrossRef Macrae JM, Dojcinovic I, Djurdjev O et al (2009) Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3:369–374CrossRef
33.
go back to reference Tan HZ (2008) A randomized controlled study on prevention of catheter-related bacteremia with gentamicin-heparin lock solution. Dissertation, Zhejiang University Tan HZ (2008) A randomized controlled study on prevention of catheter-related bacteremia with gentamicin-heparin lock solution. Dissertation, Zhejiang University
34.
go back to reference Zhang P, Yuan J, Tan H et al (2009) Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 27:206–211CrossRefPubMed Zhang P, Yuan J, Tan H et al (2009) Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 27:206–211CrossRefPubMed
35.
go back to reference Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55:1060–1068CrossRefPubMed Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55:1060–1068CrossRefPubMed
36.
go back to reference Campos RP, do Nascimento MM, Chula DC et al (2011) Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939–1945CrossRefPubMedPubMedCentral Campos RP, do Nascimento MM, Chula DC et al (2011) Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939–1945CrossRefPubMedPubMedCentral
37.
go back to reference Filiopoulos V, Hadjiyannakos D, Koutis I et al (2011) Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 33:260–268CrossRefPubMed Filiopoulos V, Hadjiyannakos D, Koutis I et al (2011) Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 33:260–268CrossRefPubMed
38.
go back to reference Lu DS (2011) Gentamicin lock solution prevents central venous catheter-related infections in hemodialysis. Med Inform 24:123–124 Lu DS (2011) Gentamicin lock solution prevents central venous catheter-related infections in hemodialysis. Med Inform 24:123–124
39.
go back to reference Broom JK, Krishnasamy R, Hawley CM et al (2012) A randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in hemodialysis patients–the HEALTHY-CATH trial. BMC Nephrol 13:146CrossRefPubMedPubMedCentral Broom JK, Krishnasamy R, Hawley CM et al (2012) A randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in hemodialysis patients–the HEALTHY-CATH trial. BMC Nephrol 13:146CrossRefPubMedPubMedCentral
40.
go back to reference Moran J, Sun S, Khababa I et al (2012) A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59:102–107CrossRefPubMed Moran J, Sun S, Khababa I et al (2012) A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59:102–107CrossRefPubMed
41.
go back to reference Sofroniadou S, Revela I, Smirloglou D et al (2012) Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study. Semin Dial 25:344–350CrossRefPubMed Sofroniadou S, Revela I, Smirloglou D et al (2012) Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study. Semin Dial 25:344–350CrossRefPubMed
42.
go back to reference Hu ZX, Xiao HQ, Fei P (2013) Application of the lock solution containing l% cefazolin/30% sodium citrate for long-term indwelling catheters in maintenance hemodialysis patient. Chin J Blood Purif 12:602–604 Hu ZX, Xiao HQ, Fei P (2013) Application of the lock solution containing l% cefazolin/30% sodium citrate for long-term indwelling catheters in maintenance hemodialysis patient. Chin J Blood Purif 12:602–604
43.
go back to reference Zacharioudakis IM, Zervou FN, Arvanitis M et al (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59:1741–1749CrossRefPubMed Zacharioudakis IM, Zervou FN, Arvanitis M et al (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59:1741–1749CrossRefPubMed
44.
go back to reference Oliver MJ, Callery SM, Thorpe KE et al (2000) Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543–2545CrossRefPubMed Oliver MJ, Callery SM, Thorpe KE et al (2000) Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543–2545CrossRefPubMed
45.
go back to reference Wang AY, Ivany JN, Perkovic V et al (2013) Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant 28:2875–2888CrossRefPubMed Wang AY, Ivany JN, Perkovic V et al (2013) Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant 28:2875–2888CrossRefPubMed
46.
go back to reference Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5:1799–1804CrossRefPubMedPubMedCentral Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5:1799–1804CrossRefPubMedPubMedCentral
Metadata
Title
Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis
Authors
Jun Zhang
Bo Wang
Rongke Li
Long Ge
Kee-Hsin Chen
Jinhui Tian
Publication date
01-04-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1490-x

Other articles of this Issue 4/2017

International Urology and Nephrology 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine